Agenda
October 10, 2023 08:00
MDT case studies in lower limb thrombosis – haematology and vascular surgery perspectives
Dr Gill Lowe
Consultant Haematologist specialising in Haemostasis and Thrombosis and has a specialist interest in problems with bleeding and thrombosis.
Dr Lowe trained in Cambridge, Manchester and Birmingham.
Prof. Alok Tiwari
Professor Alok Tiwari is a consultant vascular surgeon at University Hospitals Birmingham. He is a visiting professor of vascular surgery at Birmingham City University and honorary associate professor at University of Birmingham and the current training program director for vascular surgery in the West Midlands. He has been a consultant since 2011. He trained at Charing Cross and Westminster Medical School qualifying in 1996. He did his basic surgical training at Essex followed by a period of research in tissue engineering which was undertaken at the Royal Free Hospital in London. He was awarded his Master of Surgery for his thesis in 2003. He did his higher surgical training in Essex and London as well as 12-month fellowship in vascular and endovascular surgery at Westmead Hospital in Australia and a sabbatical working in Singapore in 2017-18. He is a fully trained vascular and endovascular surgeon with specialist interests in endovascular surgery and the management of the diabetic foot. He has more than 100 publications in all aspects of vascular surgery. He works closely with the haematology team in dealing with patient with DVT
October 10, 2023 09:15
LTC'23 Selected Poster Presentations
Prof Paul Bennett
Paul Bennett is a clinical and academic psychologist, who has worked in both NHS and universities in Bristol, Cardiff and Swansea. He has previously published research on the psychological impact of VTE, and is presently an emeritus professor of psychology at the University of Swansea and a clinical psychologist providing support for VITT patients through the auspices of Thrombosis UK.
Sarah Havord
Sarah Havord, VTE Prevention Specialist Nurse, Oxford University Hospitals NHS Foundation Trust
Sarah started her Adult Nursing training in 2011 and graduated from Oxford Brookes University in 2014 with a Hons Degree in Adult Nursing. In 2013 she worked in a surgical specialty including colorectal, gynaecology and breast cancer before joining the VTE Prevention Service. Sarah recently graduated from Oxford Brookes University with a Master's in Health Sciences - Clinical Governance in Nursing. Sarah has a passion in innovation, sustainability, and teaching, with an active role in engaging and supporting others within the thrombosis network. Her most recent work focused on the emotions experienced by those with a cancer associated VTE and currently developing a national patient information app on blood clots.
Victoria McDonnell
Sharan Reghunathan
Sharan Reghunathan is a 5th year medical student at the University of Manchester, and has completed an intercalated degree at King’s College at King’s College, in BSc in Medical Genetics with Basic Medical Sciences. He was the recipient of the Bobrow Prize in Medical Genetics. Having a keen interest in genetics, Sharan has worked with various groups looking into the impact of genetics in healthcare. Adjunct from this, Sharan’s hobbies include football, squash and playing the violin.
Inaul Hussain
Inaul Hussain IPresc, PGDipGPP, MRPharmS, is Lead Pharmacist Anticoagulation at Barking, Havering and Redbridge University Hospitals NHS Trust. He is an independent prescriber and presently undertaking an MSc in Leadership and Service Improvement. He has worked across various NHS Trusts in London, previously at Guy’s and St Thomas’ NHS Foundation Trust and educated at the University of East Anglia and University College London.
- The emotions experienced by cancer patients with a venous thromboembolism (VTE)
- Pharmacist-led warfarin review clinic
- Prevalence of Genetic Loci associated with Venous Thromboembolism: An Analysis of a Large-Scale Whole-Genome Sequencing Database of 3 Asian Populations in Singapore
- An audit to assess the appropriateness of VTE Prophylaxis at Barking, Havering and Redbridge University Hospitals NHS Trust
October 10, 2023 11:00
Sponsored Symposium – Cardinal Health
Sue Bacon
Sue Bacon is a Quality Improvement Nurse at North Bristol Trust. Previously Lead VTE prevention and Anticoagulation Specialist Nurse. Prior to this Sue ran a nurse led DVT service in Scarborough, Yorkshire. Sue has published articles in nursing journals and has authored a chapter in a Peri-Operative book. Sue was a founder Member of the UK Thromboprophylaxis Forum and Sue was a nurse representative on the VERITY Steering group (reviewing VTE data from across the UK).
October 10, 2023 12:05
"PETS Trial: Examining the benefit of graduated compression stockings in the Prevention of vEnous Thromboembolism in low-risk Surgical patients: a multicentre cluster randomised controlled trial (PETS Trial)"
Sarrah Peerbux
October 10, 2023 12:30
Endovascular management of PE
Mr Peter Mezes
October 10, 2023 14:00
LTC Masterclass: Venous Thromboembolism and Gender-Inclusive Women's Health
Prof Fionnuala Ni Ainle
Professor Ní Áinle is a Consultant Haematologist and is a Full Clinical Professor at University College Dublin (UCD) School of Medicine. She serves as Clinical Lead for National VTE Clinical Programme in Ireland. She directs the Irish Network for VTE Research and co-directs the SPHERE Research Group, UCD Conway Institute. She is actively involved in international VTE clinical trials and serves on several trial steering committees. Her translational research interests explore the role of blood coagulation and extracellular vesicles, in particular with relevance to disorders of pregnancy. She serves as a council member and “director at large” of INVENT-VTE (the International Network of VENous Thromboembolism Clinical Research Networks). She acted as a Section Coordinator (Pregnancy) on the Task Force of the 2019 ESC Guidelines on the diagnosis and management of acute Pulmonary Embolism and serves on the editorial board of several journals. She serves on the council of ISTH (class of 2028) and as vice-chair of the ISTH Guidelines and guidance committee.
Prof Marc Blondon
Dr Marc Blondon is an internal medicine and vascular medicine specialist and works in the Division of Angiology and Haemostasis of the Geneva University Hospitals, in Switzerland. He is also a clinical researcher, with a Master of Science Epidemiology from the University of Washington, in Seattle. His main research and clinical interests are the prevention of venous thromboembolism and women’s thrombosis, in particular with regards to hormones and pregnancy.
Dr Helia Robert-Ebadi
Helia Robert-Ebadi, MD, is board-certified in Internal medicine and in Angiology. She is responsible for the Angiology Unit in the Division of Angiology and Hemostasis of Geneva University Hospitals in Switzerland. Her main field of research is clinical research in venous thromboembolism (VTE), with a particular interest in the diagnosis of pulmonary embolism and deep vein thrombosis, but also other aspects of management of patients with VTE. She is currently a co-chair of the International Society on Thrombosis and Hemostasis (ISTH) Scientific and Standardization Committee (SSC) on Predictive and Diagnostic Variables in Thrombotic Disease.
Prof Marc Rodger
Dr. Marc Rodger is the Chair of the McGill University Department of Medicine, Physician-in-Chief, McGill University Health Center and the Harry Webster Thorp Professor of Medicine. Dr. Rodger’s teaching, clinical care and research focuses on venous thrombosis. Dr. Rodger co-founded the CIHR funded CanVECTOR (Canadian Venous Thrombosis Clinical Trials and Outcomes Research) Network (www.CanVECTOR.ca). Dr. Rodger also founded, past Chair and current volunteer Executive Director of INVENT (International Network of Venous Thrombosis Clinical Research Networks) (www.INVENT-VTE.com). INVENT includes 10 national research networks with over 450 investigators in over 150 research sites throughout the world.
French
Marc Rodger MD FRCPC MSc (épidémiologie)
Directeur, Département de médecine, Faculté de médecine et des sciences de la santé, Université McGill
Médecin-chef, Centre universitaire de santé McGill
Professeur de médecine Harry Webster Thorp
Le Dr Marc Rodger est directeur du Département de médecine de l'Université McGill, médecin en chef du Centre universitaire de santé McGill et titulaire de la chaire de médecine Harry Webster Thorp. L'enseignement, les soins cliniques et la recherche du Dr Rodger portent sur la thrombose veineuse. Le Dr Rodger a cofondé le réseau CanVECTOR (Réseau canadien de recherche clinique sur la thromboembolie veineuse) financé par les IRSC (www.CanVECTOR.ca). Le Dr Rodger a également fondé le réseau INVENT (Réseau international des réseaux de recherche clinique sur la thrombose veineuse) dont il est l’ancien président, et actuellement le directeur exécutif bénévole (www.INVENT-VTE.com). INVENT comprend 10 réseaux de recherche nationaux avec plus de 450 chercheurs dans plus de 150 sites de recherche à travers le monde.
Dr Barry Kevane
Dr Barry Kevane MB, PhD is a Consultant Haematologist with a specialist interest in thrombosis & haemostasis and is based in the Mater Misericordiae University Hospital and Ireland East Hospital Group. Dr Kevane is also a principal investigator with the University College Dublin (UCD) Conway Sphere Research Group, and his main areas of research interest are in translational and clinical studies in thrombosis.
Dr Leslie Skeith
Dr. Leslie Skeith is an Associate Professor and hematologist at the University of Calgary, Calgary, Alberta, Canada. Dr. Skeith's clinical and research interest is in the area of pregnancy, hormones and venous thromboembolism.
- VTE risk assessment postpartum and treatment in pregnancy
- VTE diagnosis in pregnancy
- The role of academic clinical trial research networks in supporting clinical trials in women's health: what does the future hold?
- Syndemics in women's health
- VTE in people receiving hormonal therapy
October 11, 2023 09:30
PCCS Symposium: Diagnosis and management of DVT and PE with case studies, when to offer lifelong OAC and cancer-related VTE
Prof Ahmet Fuat
Professor Ahmet Fuat has recently retired as a GP in Darlington, Co.Durham after 37 years in the same practice and 41 years as a qualified doctor. He will continue to work as a GPSI Cardiology running a genetic lipid service for County Durham and Darlington Foundation Trust, and take up a role as Medical Director for OBEROI Consulting.
He has been a GPSI Cardiology for 26 years having undertaken a Postgraduate Diploma in Cardiology at Bradford University graduating with distinction. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 2002 with local colleagues.
He has a PhD in research in heart failure diagnosis and management, which includes work on natriuretic peptides and has generated several publications that influenced guidelines and led to his recognition as an Honorary Professor at Durham University.
He holds various roles in CVD and research including the immediate past President of the Primary Care Cardiovascular Society (PCCS) which he was instrumental in reforming and current education and research lead, and GP Research Engagement lead for NENC CRN.
He has a passion for medical education and remains an active lecturer, tutor and researcher. He is a peer reviewer for most high impact Cardiovascular journals, BMJ, BJGP and research bodies. His work in community cardiology has been recognised with Fellowships from the RCGP, RCP London and RCP Edinburgh and the PCCS.
Emma Gee
Emma Gee, Nurse Consultant Thrombosis & Coagulation, Denmark Hill & PRUH
Emma graduated from Brighton University with an Adult Nursing Degree in 2001 and undertook a cross speciality rotation at Addenbrookes Hospital. After working in Perth, Australia as a surgical nurse for a year she worked in High Dependency Care for several years in Watford General and King's College Hospitals. In 2007 she joined Kings' Thrombosis Team as a Coagulation Clinical Nurse Specialist rotating through DVT, anticoagulation and VTE prevention roles.
Emma became the Nurse Consultant in Thrombosis and Coagulation with responsibility for the nursing thrombosis teams across King’s College Hospital sites in 2014 and became the lead for the VTE National Nursing and Midwifery Network at the same time. Emma completed an MSc in Advanced Practice and Leadership at King’s College London in 2018.

October 11, 2023 11:00
Sponsored Symposium – Bayer Is all VTE management the same? – Patient Journey
Dr Waseem Khan
Dr Waseem Khan is a Consultant in respiratory and general medicine airways lead.
Manchester Royal Infirmary, Manchester University NHS Foundation Trust
October 11, 2023 12:30
Sponsored Symposium - Techdow: Low Molecular Weight Heparins Should Be Prescribed by Their Brand Name
Fergus McCallum
October 11, 2023 14:00
Sponsored Session: Bayer Round Table Event Real Management of VTE – Case Studies
Dr Waseem Khan
October 12, 2023 09:30
THRIVE - Study Update and Recruitment Details: (THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment)
Sarah Whittley
Sarah Whittley is a Clinical Trial Manager within the Department of Surgery and Cancer at Imperial College London. As a Clinical Trial Manager, Sarah assists in all aspects of clinical trial conduct, from initial design through to successful delivery and dissemination of results. Sarah is also pursuing a PhD within the department.
Sarah is currently setting up the THRIVE trial, which aims to examine the most clinically and cost effective thromboprophylaxis regimen in patients undergoing superficial endovenous intervention.
October 12, 2023 11:00
Sponsored Symposium – G&N
TBC
October 12, 2023 12:30
Sponsored Symposium: AstraZeneca
Dr Will Lester
Dr Will Lester is a Haematology Consultant at University Hospitals Birmingham, Queen Elizabeth and Birmingham Women’s Hospital and an Honorary Senior Clinical Lecturer in the Institute of Cardiovascular Sciences, University of Birmingham and has been a lecturer at the National Centre for Anticoagulant Training.
His interests include thrombosis and haemostasis, obstetric and general haematology. He has received two thrombus innovation awards for work on thrombosis prevention and is a member of the Haemostasis and Thrombosis task force for the British Society of Haematology guidelines committee.
Dr Pip Nicolson
Pip is consultant haematologist at the Queen Elizabeth Hospital in Birmingham. He has a clinical interest in haemostasis, thrombosis and immunohaematology. He is also an associate professor at the University of Birmingham. His laboratory research interests include the role of platelets in venous thrombosis and thromboinflammation. He is passionate about efficient clinical research and founded the UK haematology research network HaemSTAR.
October 12, 2023 13:45
UKCPA Symposium: DOACs in cancer associated thrombosis: Sub-group challenges and considerations
Katherine Stirling
Katherine Stirling is a consultant pharmacist for anticoagulation and thrombosis at Leeds Teaching Hospitals. She has been in post since 2011. Since 2019 she has also been working for 1 day a week with Leeds CCG GP confed team on the NHSE AF project.
Her role covers all areas of thrombosis and anticoagulation including VTE prevention. She is a member of the trusts thrombosis steering group and regularly attends VTE MDT meetings. Her clinical role involves out-patient anticoagulant clinics for patients on oral and injectable anticoagulants. He is a supervisor for a PhD student looking at the barriers and enablers to the uptake of DOACs and has a research interest in the use of DOACs at extremes of weight.
Nathan Hutchinson-Jones
Nathan is the lead pharmacist for thrombosis and anticoagulation at the Royal United Hospital (RUH), Bath. He leads a team of three specialist nurses, manages a cancer associated thrombosis clinic and participates in a weekly thrombosis clinic alongside a consultant haematologist reviewing patients with complex anticoagulation needs and previous unprovoked or recurrent venous thrombosis. He is currently the research lead for the UKCPA haemostasis and thrombosis group.
Kieron Power
Kieron is the principal pharmacist for thrombosis and anticoagulation in Swansea Bay University health board. His roles include running the acute VTE service in the health board, and running specialist thrombosis and anticoagulation services on behalf of the haematology department, and leading the health boards hospital acquired thrombosis prevention programme. Kieron’s team have been recognised for their work in improving the care of patients with cancer associated thrombosis with numerous awards and commendations over recent years
October 12, 2023 16:00
LTC Masterclass New learning in Cancer Associated Thrombosis
Dr Jean Connors
October 13, 2023 12:30
VTE Specialist Network Questions & Answers in VTE Prevention and Management
Emma Gee
Emma Gee, Nurse Consultant Thrombosis & Coagulation, Denmark Hill & PRUH
Emma graduated from Brighton University with an Adult Nursing Degree in 2001 and undertook a cross speciality rotation at Addenbrookes Hospital. After working in Perth, Australia as a surgical nurse for a year she worked in High Dependency Care for several years in Watford General and King's College Hospitals. In 2007 she joined Kings' Thrombosis Team as a Coagulation Clinical Nurse Specialist rotating through DVT, anticoagulation and VTE prevention roles.
Emma became the Nurse Consultant in Thrombosis and Coagulation with responsibility for the nursing thrombosis teams across King’s College Hospital sites in 2014 and became the lead for the VTE National Nursing and Midwifery Network at the same time. Emma completed an MSc in Advanced Practice and Leadership at King’s College London in 2018.
Zoe King
Hello, My name is Zoe and I am a ward sister and the VTE lead at Spire Alexandra hospital in Kent. I have also worked in acute medicine and stroke before starting at the Alexandra as a staff nurse. The hospital specialises in elective surgery, as well as having an outpatient department with minor ops and imaging. The Alexandra specialises in orthopaedics so complete lots of joint arthroplasty operations. We are a VTE exemplar centre and had this status renewed this year in March. My role involves ensuring we continue the good practices required to be an exemplar centre that help to ensure our patients receive optimal care for prevention and treatment of VTE.
Andrea Croft
Originally trained as an SEN in the Royal Air Force, following a four year break abroad Andrea returned to the UK and in 1992 undertook Project 2000. After inheriting the management of the hospital Warfarin clinic in Bridgend General Hospital in 1995 she developed an interest in Anticoagulation. Since 2002 Andrea has pioneered and championed the need to manage all hospitalised patients appropriately keeping them safe from the associated risks of developing a Hospital Acquired Thrombosis (HAT). Since 2009 Andrea has held the role of HAT Project Lead in Abertawe Bro Morgannwg University Health Board. Andrea is Wales her passion and enthusiasm for Anticoagulation have taken her as far afield as Australia. In 2015 3 hospitals in Andrea's Health Board were recognised as Thrombosis Exemplar Centres.
Huw Rowswell
Huw Rowswell Consultant Nurse thrombosis, University Hospitals Plymouth NHS Trust
Vice Chair Clinical Leaders of Thrombosis and Trustee British Society of Haematology
Huw trained in London at St Marys Paddington and initially worked in respiratory medicine before moving to critical care then helping set up the acute care team in Plymouth. He joined the Plymouth thrombosis team in 2009 when it became an exemplar centre.
He became a nurse consultant in 2016 with responsibility for investigating hospital acquired VTE giving real time feedback to clinicians. He completed his MSc with a dissertation on VTE in cardiac surgery comparing emergency with elective patients and has published many articles on VTE outcome data. He is the UK representative for the “All China nursing VTE alliance” and was appointed the hospital VTE lead and chair of the thrombosis committee in 2020.
Sue Bacon
Sue Bacon is a Quality Improvement Nurse at North Bristol Trust. Previously Lead VTE prevention and Anticoagulation Specialist Nurse. Prior to this Sue ran a nurse led DVT service in Scarborough, Yorkshire. Sue has published articles in nursing journals and has authored a chapter in a Peri-Operative book. Sue was a founder Member of the UK Thromboprophylaxis Forum and Sue was a nurse representative on the VERITY Steering group (reviewing VTE data from across the UK).
Becs Walsh
Becs Walsh, Lead Pharmacist for Anticoagulation & Thrombosis Prevention, Sheffield Teaching Hospital NHS Foundation Trust
Becs graduated from Bradford University with a Masters degree in Pharmacy in 2002 and undertook pre-registration pharmacy training in Sheffield, qualifying in 2003. She completed a post-graduate diploma in Clinical Pharmacy in 2005 completing rotations through various medical and surgical specialties. She worked in oncology and palliative care before becoming the first pharmacist to be employed in the role of thrombosis prevention & anticoagulation at Sheffield in 2009. Becs is an active member of the Yorkshire & Humber Anticoagulation Pharmacists group and professional secretary of the local thrombosis committee.
Carolyn Warren
Carolyn Warren - National Clinical Specialist Blood Transfusion and VTE Prevention
Worked for Spire Healthcare since 2016
Worked in my current position since January 2023. This national position has a remit of 39 Spire hospitals situated in Scotland, Wales and England.
Overview of current role for VTE prevention
• Education/training/professional development
• Resource development and training packages with clinical competency development
• Hospital site visits
• Virtual education
• Organising conferences
• Review of all PE RCA’s within Spire Healthcare
• Support for all Spire hospitals to gain their VTE Exemplar status
• National Committee meetings
Worked in various roles since commencing at Spire Healthcare, both at hospital and national level.
Other positions and areas worked
• Worked in Australia from 1995- 2015 in various roles at busy tertiary hospitals, both clinically and within education and training clinicians
• Worked in Hong Kong from 1988-1994 as a midwife
• Worked in Anglesey from 1986 -1988 as a midwife
• Trained on the Wirral as a Registered Nurse
I am passionate to support VTE prevention. It brings me great joy when I visit the hospitals and witness all the great work and enthusiasm that the hospital VTE Leads and Links provide within all their departments to support our patients with an MDT approach for our patients’ journey.
Rose Gibson
I have been Specialist Clinical Practitioner for VTE Prevention at RCHT since April 2023. I graduated from the University of Plymouth as a registered nurse in 2014 and have worked at RCHT Treliske ever since. My background is predominately in acute medicine with a two year stint as a Specialist Respiratory Nurse socialising in cystic fibrosis and bronchiectasis.
Loreena Bacarro
Loreena Bacarro is the VTE prevention clinical nurse specialist at Kings College Hospital NHS Foundation Trust. She has completed her Bachelor's degree in Nursing in the Philippines and worked as an Intensive Care Nurse before coming to the UK in 2014. She started as a Hyperacute Stroke unit staff nurse and moved up the career ladder as an Anticoagulation CNS in 2018 and currently enjoys both the clinical and the VTE prevention role.
Lakshman Thuraisingham
- Root cause analysis of hospital acquired thrombosis
- Lower limb immobilisation
- VTE education and training

October 13, 2023 14:00
LTC Masterclass: News at XI: Moving beyond the direct oral anticoagulants
Prof Jeff Weitz
Jeffrey I. Weitz, OC, MD, FRCPC, FACP, FRSC, FACC, FESC, FCAHS, FAHA
Heart & Stroke Foundation/J.F. Mustard Chair in Cardiovascular Research
Canada Research Chair (Tier 1) in Thrombosis
Dr. Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Executive Director of the Thrombosis and Atherosclerosis Research Institute and Past President of Council for the International Society on Thrombosis and Haemostasis. Board Certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Weitz focuses his clinical practice on patients with thrombotic disorders. His research spans the spectrum from basic studies in the biochemistry of blood coagulation and fibrinolysis to animal models of thrombosis and on to clinical trials of antithrombotic therapy. The breadth of his work is highlighted by his over 640 publications in journals as diverse as the Journal of Clinical Investigation, Journal of Biological Chemistry, Biochemistry, Circulation, Blood, Annals of Internal Medicine, New England Journal of Medicine and Lancet, and 76 book chapters. The recipient of numerous awards, Dr. Weitz was appointed as an Officer of the Order of Canada and is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences.